KU Leuven spin-off AstriVax raises €30m to build vaccine platform 25-Aug-2022 By Jane Byrne Closing on €30m, vaccine producer, AstriVax, has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
China's Premier demands ‘clear explanation’ of vaccine scandal 24-Jul-2018 By Ben Hargreaves China’s authorities’ condemnation of Changsheng Biotechnology, after it was found to have falsified data regarding a rabies virus, has caused public concern over the domestic vaccine market.